首頁>> 新聞動態>> 學術活動

學術活動

AAV vector development for human gene therapy of Hemophilia A

發表日期:2017-09-18 來源: 放大縮小

題目:AAV vector development for human gene therapy of Hemophilia A

主講人:Dr. Weidong Xiaoprofessor in temple university, America

時間:2017922,星期五上午10:00 – 12:30

地點:廣州生物醫藥與健康研究院A326

主持人:陳淩研究員

主講人簡介: Dr. Weidong Xiao qualified in chemistry from University of Sci. and Tec. of China and obtained a PhD in Molecular Virology from University of North Carolina. Latter in 1996,he became a Postdoctoral Fellow of the Institute for Human Gene Therapy University of Pennsylvania, Philadelphia. He is now a professor of the temple university America, and an assistant professor in Institute of Molecular Medicine of Huaqiao University, China. He is the first one in finding the decoded gene sequence of type AAV and constructing the vect or of type AAV for applying. Dr. Xiao is a famous professor in virus vector and gene engineering. His research achievement had been published in several international academic journals, such as PNAS Journal of Virology Hepatology Molecular Therapy Blood and so on. He also owns several American patents invention.
附件:
    Baidu
    map